Form 13-F position report

INOGEN INC

Reported by FRED ALGER MANAGEMENT LLC

INGN CUSIP 45780L104 Manager CIK 0000003520

Reported 1,077,518 shares, down 46,983 (4.2%) from the prior quarter.

Reported value -11.3%; share count -4.2% vs. the prior quarter.

Reduced
% of reported 13F value 0.06% This manager · Q2 2023
Shares 1,077,518 Quarter-end amount reported
Reported value $12,445,333 Fair value at quarter end
Consecutive quarters held 28 Through Q2 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 10032000
2021-12-31 6392000
2022-03-31 16511000
2022-06-30 12830000
2022-09-30 26326000
2022-12-31 22488224
2023-03-31 14033773
2023-06-30 12445333
2023-09-30 5554842
2023-12-31 4342431
2024-03-31 6242250
2024-06-30 5953754
2024-09-30 6914568
2024-12-31 5511124
2025-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

15 quarters
Quarterly reported position history for INOGEN INC held by FRED ALGER MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2025 Reduced 0 -600,995 (-100.0%) 0 $0 2025-05-16
Q4 2024 Reduced 600,995 -111,847 (-15.7%) 0.03% $5,511,124 2025-02-14
Q3 2024 Reduced 712,842 -19,477 (-2.7%) 0.03% $6,914,568 2024-11-14
Q2 2024 Reduced 732,319 -41,194 (-5.3%) 0.03% $5,953,754 2024-08-14
Q1 2024 Reduced 773,513 -17,458 (-2.2%) 0.03% $6,242,250 2024-05-15
Q4 2023 Reduced 790,971 -273,175 (-25.7%) 0.02% $4,342,431 2024-02-14
Q3 2023 Reduced 1,064,146 -13,372 (-1.2%) 0.03% $5,554,842 2023-11-14
Q2 2023 Reduced 1,077,518 -46,983 (-4.2%) 0.06% $12,445,333 2023-08-14
Q1 2023 Reduced 1,124,501 -16,454 (-1.4%) 0.08% $14,033,773 2023-05-15
Q4 2022 Added 1,140,955 +56,711 (5.2%) 0.12% $22,488,224 2023-02-14
Q3 2022 Added 1,084,244 +553,626 (104.3%) 0.13% $26,326,000 2022-11-15
Q2 2022 Added 530,618 +21,341 (4.2%) 0.06% $12,830,000 2022-08-15
Q1 2022 Added 509,277 +321,294 (170.9%) 0.05% $16,511,000 2022-05-16
Q4 2021 Reduced 187,983 -44,842 (-19.3%) 0.02% $6,392,000 2022-02-14
Q3 2021 Added 232,825 +3,603 (1.6%) 0.02% $10,032,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

176 managers reported INOGEN INC for Q2 2023.

Managers reporting INOGEN INC in Q2 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BROWN CAPITAL MANAGEMENT LLC Unchanged 2,207,535 0 0.36% $25,497,029 29 qtrs
BlackRock Inc Reduced 1,729,549 -2,247,895 < 0.01% $19,976,291 33 qtrs
VANGUARD GROUP INC Reduced 1,480,064 -775,326 < 0.01% $17,094,740 38 qtrs
Camber Capital Management LP Added 1,150,000 +175,000 0.43% $13,283,000 7 qtrs
FRED ALGER MANAGEMENT LLC This report Reduced 1,077,518 -46,983 0.06% $12,445,333 28 qtrs
MILLENNIUM MANAGEMENT LLC Added 924,997 +445,099 < 0.01% $10,683,715 27 qtrs
Balyasny Asset Management LLC Added 581,618 +278,227 0.01% $6,717,688 2 qtrs
DIMENSIONAL FUND ADVISORS LP Reduced 557,660 -301,588 < 0.01% $6,441,166 32 qtrs
BRIDGEWAY CAPITAL MANAGEMENT LLC Added 521,900 +235,000 0.14% $6,027,945 3 qtrs
Meros Investment Management LP Added 513,310 +231,109 2.94% $5,928,731 7 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2023
Filed
August 14, 2023
Filing type
13F-HR
Position type
Common

Voting authority reported

Sole
799,728
Shared
0
None
277,790

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.